GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ourofino SA (BSP:OFSA3) » Definitions » Cyclically Adjusted PS Ratio

Ourofino (BSP:OFSA3) Cyclically Adjusted PS Ratio : 1.26 (As of Dec. 11, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Ourofino Cyclically Adjusted PS Ratio?

As of today (2024-12-11), Ourofino's current share price is R$21.02. Ourofino's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2024 was R$16.62. Ourofino's Cyclically Adjusted PS Ratio for today is 1.26.

The historical rank and industry rank for Ourofino's Cyclically Adjusted PS Ratio or its related term are showing as below:

BSP:OFSA3' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.14   Med: 1.31   Max: 1.5
Current: 1.31

During the past years, Ourofino's highest Cyclically Adjusted PS Ratio was 1.50. The lowest was 1.14. And the median was 1.31.

BSP:OFSA3's Cyclically Adjusted PS Ratio is ranked better than
72.34% of 640 companies
in the Drug Manufacturers industry
Industry Median: 2.56 vs BSP:OFSA3: 1.31

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Ourofino's adjusted revenue per share data for the three months ended in Sep. 2024 was R$5.255. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is R$16.62 for the trailing ten years ended in Sep. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Ourofino Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Ourofino's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ourofino Cyclically Adjusted PS Ratio Chart

Ourofino Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Ourofino Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 1.56 1.17 1.26

Competitive Comparison of Ourofino's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Ourofino's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ourofino's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ourofino's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Ourofino's Cyclically Adjusted PS Ratio falls into.



Ourofino Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Ourofino's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=21.02/16.62
=1.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ourofino's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2024 is calculated as:

For example, Ourofino's adjusted Revenue per Share data for the three months ended in Sep. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=5.255/162.3424*162.3424
=5.255

Current CPI (Sep. 2024) = 162.3424.

Ourofino Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201412 2.511 94.194 4.328
201503 1.613 97.799 2.678
201506 2.459 100.006 3.992
201509 2.765 101.392 4.427
201512 3.048 104.247 4.747
201603 1.813 106.979 2.751
201606 2.487 108.851 3.709
201609 2.321 109.986 3.426
201612 1.826 110.802 2.675
201703 1.394 111.869 2.023
201706 2.557 112.115 3.703
201709 2.412 112.777 3.472
201712 3.003 114.068 4.274
201803 1.704 114.868 2.408
201806 2.995 117.038 4.154
201809 2.972 117.881 4.093
201812 3.250 118.340 4.458
201903 1.686 120.124 2.279
201906 3.294 120.977 4.420
201909 2.862 121.292 3.831
201912 3.642 123.436 4.790
202003 2.074 124.092 2.713
202006 3.198 123.557 4.202
202009 4.174 125.095 5.417
202012 4.087 129.012 5.143
202103 3.129 131.660 3.858
202106 4.281 133.871 5.191
202109 4.353 137.913 5.124
202112 5.024 141.992 5.744
202203 3.750 146.537 4.154
202206 4.376 149.784 4.743
202209 5.221 147.800 5.735
202212 6.003 150.207 6.488
202303 3.109 153.352 3.291
202306 4.312 154.519 4.530
202309 4.904 155.464 5.121
202312 5.219 157.148 5.392
202403 3.318 159.372 3.380
202406 4.040 161.052 4.072
202409 5.255 162.342 5.255

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Ourofino  (BSP:OFSA3) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Ourofino Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Ourofino's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Ourofino Business Description

Traded in Other Exchanges
N/A
Address
Anhanguera Highway SP 330, Block C, 2nd floor, Km 298, Industrial District, Cravinhos, SP, BRA, 14140-000
Ouro Fino Saude Animal Participacoes SA is engaged in the production and sale of veterinary drugs, vaccines, and other products for cattle, pigs, poultry, sheep, horses goats, and pets. The company's reportable segments are Production animals, Companion animals, and International operations. It generates maximum revenue from the Production animals segment. The product portfolio includes Anticoccidials, Antimastitics, Biological, Ectoparasiticides, Endectocides, and others.

Ourofino Headlines

No Headlines